QUCY

Conviction 57HealthcareScan · Thu, Jun 25, 2026

Bullish engulfing

QUCY$1.48+0.68%

ResistanceSupportVol 14

Vol MA14 3.53M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Quantum Cyber N.V.PHARMACEUTICAL PREPARATIONSquantum-cyber.ai ↗

Price1.48

Change+0.68%

Gap-0.68%

Rel volume0.18×

Avg volume4.79M

Avg $ vol10.46M

SMA 202.03

SMA 501.59

SMA 200—

Price vs 50-7.20%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 2.47

RSI (14)41

MACD hist-0.12

MACD cross—

Stoch %K / %D11 / 8

ADX (14)29

+DI / −DI28 / 24

RSI divergence—

MACD divergence—

ATR %+24.61%

ADR %13.54%

52w high3.56

52w low0.3228

From 52w high-58.43%

Above 52w low+358.49%

New 52w highNo

SqueezeOff

Bollinger width77.34%

%B0.15

Donchian pos5.95%

Donchian high3.14

Donchian low1.38

AVWAP (52w high)3.16

vs AVWAP high-53.10%

AVWAP (52w low)2.12

vs AVWAP low-30.18%

OBV trendFlat

Chaikin MF (20)-0.37

Today vs 20d0.18×

Avg vol (14d)3.53M

Avg vol (20d)4.79M

Avg $ vol (20d)10.46M

Market cap21.7M

RS 3m (vs SPY)+182.63%

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank14.2

1 week-22.11%

1 month-57.35%

3 months+196.41%

6 months—

1 year—

YTD+95.15%

P/E-1.34

P/B4.73

P/S40.40

P/FCF-1.98

EPS-2.70

Div yield—

ROE-353.23%

ROA-210.04%

Debt/Eq0.21

Current2.11

EV/EBITDA-1.16

Gross margin72.58%

Net margin—

Rev growth-39.92%

EPS growth24.95%

Price target—

Target upside—

Analyst rating—

Institutional1.33%

Ent. value17.96M

Revenue—

Net income-5.08M

Gross profit—

Free cash flow-10.98M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out22.77M

Employees13

ListedFri, Nov 5, 2021

Free float11.37M

Float %90.8%

Short interest1.52M

Days to cover0.1d

Short volume47.9%

Squeeze score33 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction57 / 100

Pattern quality—

Tech rank14.2 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish engulfing

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in QUCY

All disclosures →

No recent disclosed trades by Congress in QUCY. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in QUCY · 4 buys

Insider	Side	Shares	Value	Traded	Filed
Ben-Tzvi Avraham Director · Ordinary Shares · 2026-05-08	Grant	137.14K	$0	2026-05-08	2026-05-26
NATAN DAVID Director · Ordinary Shares · 2026-05-08	Grant	137.14K	$0	2026-05-08	2026-05-21
Lazar David E. Chief Executive Officer · Series E Preferred Shares · 2026-04-22	Grant	1M	$1.5M	2026-04-22	2026-04-28
Lazar David E. Chief Executive Officer · Series D Preferred Shares · 2026-04-22	Grant	1M	$1.5M	2026-04-22	2026-04-28
Lazar David E. Chief Executive Officer · Ordinary Shares · 2026-04-22	Other	—	—	2026-04-22	2026-04-28

SEC filings

EDGAR filings in QUCY · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.